Structure-based design of macrocyclic factor XIa inhibitors: Discovery of the macrocyclic amide linker
JR Corte, T Fang, H Osuna, DJP Pinto… - Journal of Medicinal …, 2017 - ACS Publications
… Introduction of the amide moiety into the 12-membered macrocyclic linker 22 increased the
… The amide moiety, which led to a significant improvement in terms of both FXIa activity and …
… The amide moiety, which led to a significant improvement in terms of both FXIa activity and …
Structure based design of macrocyclic factor XIa inhibitors: Discovery of cyclic P1 linker moieties with improved oral bioavailability
CG Clark, KA Rossi, JR Corte, T Fang… - Bioorganic & Medicinal …, 2019 - Elsevier
… inhibitors with cyclic P1 linkers was designed based on the X-ray crystal structure of 1. By
constraining the P1 linker … , while removing the tetrazole moiety and acrylamide proton, both …
constraining the P1 linker … , while removing the tetrazole moiety and acrylamide proton, both …
Macrocyclic inhibitors of Factor XIa: Discovery of alkyl-substituted macrocyclic amide linkers with improved potency
JR Corte, W Yang, T Fang, Y Wang, H Osuna… - Bioorganic & Medicinal …, 2017 - Elsevier
… , between the NH of the amide moiety in the macrocyclic linker and the carbonyl of Leu41 in
… that the alkyl backbone of the macrocyclic amide linker did not fully access the hydrophobic …
… that the alkyl backbone of the macrocyclic amide linker did not fully access the hydrophobic …
Structure-based design of inhibitors of coagulation factor XIa with novel P1 moieties
DJP Pinto, JM Smallheer, JR Corte, EJD Austin… - Bioorganic & Medicinal …, 2015 - Elsevier
… The m-chlorophenyl P1 moiety is orthogonal to the urea linker, with the urea carbonyl oriented
directly into the oxyanion hole and capable of forming strong hydrogen bond interactions …
directly into the oxyanion hole and capable of forming strong hydrogen bond interactions …
Structure-based design and preclinical characterization of selective and orally bioavailable factor XIa inhibitors: demonstrating the power of an integrated S1 protease …
E Lorthiois, J Roache, D Barnes-Seeman… - Journal of medicinal …, 2020 - ACS Publications
… We then focused on the linker between the S1β and the prime site with an aim to enhance
… of a polar moiety could introduce additional conformational bias in the linker and lower the …
… of a polar moiety could introduce additional conformational bias in the linker and lower the …
Studies on fragment-based design of allosteric inhibitors of human factor XIa
RS Boothello, NV Sankaranarayanan… - Bioorganic & medicinal …, 2020 - Elsevier
… We also show that certain related linkers, eg, more rigid, aromatic linkers, are not preferred,
which points to the interesting landscape of heparin-binding site of hFXIa. Overall, this work …
which points to the interesting landscape of heparin-binding site of hFXIa. Overall, this work …
Orally bioavailable amine-linked macrocyclic inhibitors of factor XIa
T Fang, JR Corte, PJ Gilligan, Y Jeon, H Osuna… - Bioorganic & Medicinal …, 2020 - Elsevier
… Since efforts to reduce PSA in the P2 prime region led to a loss in both FXIa affinity and
metabolic stability, we turned our attention to modifying the amide moiety in the macrocyclic linker…
metabolic stability, we turned our attention to modifying the amide moiety in the macrocyclic linker…
Discovery of a high affinity, orally bioavailable macrocyclic FXIa inhibitor with antithrombotic activity in preclinical species
W Yang, Y Wang, A Lai, CG Clark… - Journal of Medicinal …, 2020 - ACS Publications
… Oral factor XIa (FXIa) inhibitors may provide a promising new … cyclic carbamate P1 linker
which provided improved oral … imidazole core as well as various linkers to the P1 group led …
which provided improved oral … imidazole core as well as various linkers to the P1 group led …
Discovery of allosteric modulators of factor XIa by targeting hydrophobic domains adjacent to its heparin-binding site
R Karuturi, RA Al-Horani, SC Mehta… - Journal of medicinal …, 2013 - ACS Publications
… moiety on an otherwise identical base scaffold. Both inhibitors contain a minimum of 10
linker atoms, yet the additional triazole of 28S is likely to impart significant rigidity to the linker in …
linker atoms, yet the additional triazole of 28S is likely to impart significant rigidity to the linker in …
Triazol: a privileged scaffold for proteolysis targeting chimeras
LW Xia, MY Ba, W Liu, W Cheng, CP Hu… - Future medicinal …, 2019 - Taylor & Francis
… triazole moiety as a privileged scaffold in the interval linker for … By switching the alkyl linker
to PEG and other linkers, other … inhibitors coupled with the thalidomide family moiety were …
to PEG and other linkers, other … inhibitors coupled with the thalidomide family moiety were …
相关搜索
- macrocyclic factor xia inhibitors
- factor xi xia inhibitors
- factor xia inhibitor hydroxyquinolin 2
- serpins antithrombin factor xia inhibition
- tetrahydroquinoline derivatives xia inhibitors
- xia inhibitor treatment of thromboembolic disorders
- preclinical characterization xia inhibitors
- factor xia inhibitors anticoagulation therapy
- factor xia inhibitors nonclassical interactions
- macrocyclic inhibitors amide linkers
- human factor xia promising inhibitors
- allosteric inhibitors factor xia
- peptidomimetic inhibitors factor xia
- amide linker xia inhibitors
- heparin acceleration factor xia inhibition
- linker moieties structure based design